These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

666 related articles for article (PubMed ID: 19264847)

  • 41. Celecoxib potentiates the anticancer effect of cisplatin on vulvar cancer cells independently of cyclooxygenase.
    Kim SH; Kim SH; Song YC; Song YS
    Ann N Y Acad Sci; 2009 Aug; 1171():635-41. PubMed ID: 19723114
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Overexpression of Survivin and XIAP in MDR cancer cells unrelated to P-glycoprotein.
    Shi Z; Liang YJ; Chen ZS; Wang XH; Ding Y; Chen LM; Fu LW
    Oncol Rep; 2007 Apr; 17(4):969-76. PubMed ID: 17342344
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Reversal of p-glycoprotein-mediated multidrug resistance by macrocyclic bisbibenzyl derivatives in adriamycin-resistant human myelogenous leukemia (K562/A02) cells.
    Li X; Sun B; Zhu CJ; Yuan HQ; Shi YQ; Gao J; Li SJ; Lou HX
    Toxicol In Vitro; 2009 Feb; 23(1):29-36. PubMed ID: 18938236
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The COX-2 inhibitor Celecoxib enhances the sensitivity of KB/VCR oral cancer cell lines to Vincristine by down-regulating P-glycoprotein expression and function.
    Yan YX; Li WZ; Huang YQ; Liao WX
    Prostaglandins Other Lipid Mediat; 2012 Jan; 97(1-2):29-35. PubMed ID: 21835258
    [TBL] [Abstract][Full Text] [Related]  

  • 45. COX-2 contributes to P-glycoprotein-mediated multidrug resistance via phosphorylation of c-Jun at Ser63/73 in colorectal cancer.
    Sui H; Zhou S; Wang Y; Liu X; Zhou L; Yin P; Fan Z; Li Q
    Carcinogenesis; 2011 May; 32(5):667-75. PubMed ID: 21296766
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Suppression of RelA/p65 nuclear translocation independent of IkappaB-alpha degradation by cyclooxygenase-2 inhibitor in gastric cancer.
    Wong BC; Jiang Xh; Fan XM; Lin MC; Jiang SH; Lam SK; Kung HF
    Oncogene; 2003 Feb; 22(8):1189-97. PubMed ID: 12606945
    [TBL] [Abstract][Full Text] [Related]  

  • 47. 15-Hydroxyprostaglandin-dehydrogenase is involved in anti-proliferative effect of non-steroidal anti-inflammatory drugs COX-1 inhibitors on a human medullary thyroid carcinoma cell line.
    Quidville V; Segond N; Lausson S; Frenkian M; Cohen R; Jullienne A
    Prostaglandins Other Lipid Mediat; 2006 Oct; 81(1-2):14-30. PubMed ID: 16997128
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Combination of cyclooxygenase-2 inhibitor and doxorubicin increases the growth inhibition and apoptosis in human hepatocellular carcinoma cells.
    Pan YY; Xu SP; Jia XY; Xu HQ; Zhang Y; Rui LX; Wei W
    Exp Oncol; 2007 Mar; 29(1):23-9. PubMed ID: 17431384
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Drug-induced alterations to gene and protein expression in intestinal epithelial cell 6 cells suggest a role for calpains in the gastrointestinal toxicity of nonsteroidal anti-inflammatory agents.
    Raveendran NN; Silver K; Freeman LC; Narvaez D; Weng K; Ganta S; Lillich JD
    J Pharmacol Exp Ther; 2008 May; 325(2):389-99. PubMed ID: 18281595
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Dietary zinc modulation of COX-2 expression and lingual and esophageal carcinogenesis in rats.
    Fong LY; Zhang L; Jiang Y; Farber JL
    J Natl Cancer Inst; 2005 Jan; 97(1):40-50. PubMed ID: 15632379
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Cyclooxygenase inhibitors not inhibit resting lung cancer A549 cell proliferation.
    Duan W; Zhang L
    Prostaglandins Leukot Essent Fatty Acids; 2006 May; 74(5):317-21. PubMed ID: 16618538
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effects of non-steroidal anti-inflammatory drugs on cyclo-oxygenase and lipoxygenase activity in whole blood from aspirin-sensitive asthmatics vs healthy donors.
    Gray PA; Warner TD; Vojnovic I; Del Soldato P; Parikh A; Scadding GK; Mitchell JA
    Br J Pharmacol; 2002 Dec; 137(7):1031-8. PubMed ID: 12429575
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Indomethacin induces cellular morphological change and migration via epithelial-mesenchymal transition in A549 human lung cancer cells: a novel cyclooxygenase-inhibition-independent effect.
    Kato T; Fujino H; Oyama S; Kawashima T; Murayama T
    Biochem Pharmacol; 2011 Dec; 82(11):1781-91. PubMed ID: 21840302
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Cyclooxygenase-2 inhibitors reverse chemoresistance phenotype in medullary thyroid carcinoma by a permeability glycoprotein-mediated mechanism.
    Zatelli MC; Luchin A; Piccin D; Tagliati F; Bottoni A; Vignali C; Bondanelli M; degli Uberti EC
    J Clin Endocrinol Metab; 2005 Oct; 90(10):5754-60. PubMed ID: 16091477
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Quinoline derivative KB3-1 potentiates paclitaxel induced cytotoxicity and cycle arrest via multidrug resistance reversal in MES-SA/DX5 cancer cells.
    Koo JS; Choi WC; Rhee YH; Lee HJ; Lee EO; Ahn KS; Bae HS; Ahn KS; Kang JM; Choi SU; Kim MO; Lu J; Kim SH
    Life Sci; 2008 Nov; 83(21-22):700-8. PubMed ID: 18845169
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Significance of COX-2 expression in human esophageal squamous cell carcinoma.
    Zhi H; Wang L; Zhang J; Zhou C; Ding F; Luo A; Wu M; Zhan Q; Liu Z
    Carcinogenesis; 2006 Jun; 27(6):1214-21. PubMed ID: 16352617
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Prostaglandin E2 release in gastric antral mucosa of guinea-pigs: basal PGE2 release by cyclo-oxygenase 2 and ACh-stimulated PGE2 release by cyclo-oxygenase 1.
    Shimamoto C; Nakanishi Y; Katsu K; Nakano T; Kubota T; Mori H; Nakahari T
    Exp Physiol; 2006 Nov; 91(6):1015-24. PubMed ID: 16945943
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Celecoxib enhances doxorubicin-induced cytotoxicity in MDA-MB231 cells by NF-kappaB-mediated increase of intracellular doxorubicin accumulation.
    van Wijngaarden J; van Beek E; van Rossum G; van der Bent C; Hoekman K; van der Pluijm G; van der Pol MA; Broxterman HJ; van Hinsbergh VW; Löwik CW
    Eur J Cancer; 2007 Jan; 43(2):433-42. PubMed ID: 17097285
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effects of selective PGE2 receptor antagonists in esophageal adenocarcinoma cells derived from Barrett's esophagus.
    Piazuelo E; Jiménez P; Strunk M; Santander S; García A; Esteva F; Lanas A
    Prostaglandins Other Lipid Mediat; 2006 Dec; 81(3-4):150-61. PubMed ID: 17085323
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The inhibitory effect of Gleditsia sinensis on cyclooxygenase-2 expression in human esophageal squamous cell carcinoma.
    Pak KC; Lam KY; Law S; Tang JC
    Int J Mol Med; 2009 Jan; 23(1):121-9. PubMed ID: 19082515
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 34.